Monophasic strains of Salmonella Typhimurium have rapidly become one of the most commonly found Salmonella serotypes in several species of animals and in clinical isolates of humans. According to the Scientific Opinion on monitoring and assessment of the public health risk of ‘Salmonella Typhimurium-like strains’ [The EFSA Journal 2010; 8(10):1826.], adopted by the Panel on Biological Hazards of EFSA on 22 September 2010, monophasic Salmonella Typhimurium strains with the antigenic formula 1,4,[5],12:i:- are considered as variants of Salmonella Typhimurium and pose a public health risk comparable to that of other Salmonella Typhimurium strains.
Recital 8, Commission Regulation (EU) No 517/2011 of 25 May 2011 implementing Regulation (EC) No 21…
In forcesince 25 May 2011